Annual D&A
N/A
December 31, 2023
Summary
- RLMD annual depreciation & amortization is not available.
Performance
RLMD Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 30, 2024
Summary
- RLMD quarterly depreciation & amortization is not available.
Performance
RLMD Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 30, 2024
Summary
- RLMD TTM depreciation & amortization is not available.
Performance
RLMD TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
RLMD Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RLMD Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Relmada Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(0.0%) | $500.00(-61.5%) |
| Dec 2021 | $1300.00(-65.8%) | $0.00(0.0%) | $1300.00(-38.1%) |
| Sep 2021 | - | $0.00(-100.0%) | $2100.00(-30.0%) |
| Jun 2021 | - | $500.00(-37.5%) | $3000.00(-14.3%) |
| Mar 2021 | - | $800.00(0.0%) | $3500.00(-5.4%) |
| Dec 2020 | $3800.00(+72.7%) | $800.00(-11.1%) | $3700.00(+27.6%) |
| Sep 2020 | - | $900.00(-10.0%) | $2900.00(-6.5%) |
| Jun 2020 | - | $1000.00(0.0%) | $3100.00(-3.1%) |
| Mar 2020 | - | $1000.00(-9.1%) | $3200.00(-30.4%) |
| Dec 2019 | $2200.00(-55.1%) | - | - |
| Sep 2019 | - | $1100.00(0.0%) | $4600.00(-6.1%) |
| Jun 2019 | $4900.00(+88.5%) | $1100.00(0.0%) | $4900.00(+4.3%) |
| Mar 2019 | - | $1100.00(-15.4%) | $4700.00(+11.9%) |
| Dec 2018 | - | $1300.00(-7.1%) | $4200.00(+20.0%) |
| Sep 2018 | - | $1400.00(+55.6%) | $3500.00(+34.6%) |
| Jun 2018 | $2600.00(-97.0%) | $900.00(+50.0%) | $2600.00(-87.0%) |
| Mar 2018 | - | $600.00(0.0%) | $20.00 K(-53.2%) |
| Dec 2017 | - | $600.00(+20.0%) | $42.70 K(-35.0%) |
| Sep 2017 | - | $500.00(-97.3%) | $65.70 K(-23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | $85.30 K(+55.7%) | $18.30 K(-21.5%) | $85.40 K(-3.4%) |
| Mar 2017 | - | $23.30 K(-1.3%) | $88.40 K(-4.6%) |
| Dec 2016 | - | $23.60 K(+16.8%) | $92.70 K(+28.6%) |
| Sep 2016 | - | $20.20 K(-5.2%) | $72.10 K(+31.3%) |
| Jun 2016 | $54.80 K(+489.2%) | $21.30 K(-22.8%) | $54.90 K(+48.8%) |
| Mar 2016 | - | $27.60 K(+820.0%) | $36.90 K(+215.4%) |
| Dec 2015 | - | $3000.00(0.0%) | $11.70 K(+36.0%) |
| Sep 2015 | - | $3000.00(-9.1%) | $8600.00(-6.5%) |
| Jun 2015 | $9300.00(+304.3%) | $3300.00(+37.5%) | $9200.00(+55.9%) |
| Mar 2015 | - | $2400.00(-2500.0%) | $5900.00(+63.9%) |
| Dec 2014 | - | -$100.00(-102.8%) | $3600.00(-5.3%) |
| Sep 2014 | - | $3600.00(+3500.0%) | $3800.00(+850.0%) |
| Jun 2014 | $2300.00(+666.7%) | - | - |
| Feb 2014 | - | $100.00(0.0%) | $400.00(+33.3%) |
| Nov 2013 | - | $100.00(0.0%) | $300.00(+50.0%) |
| Aug 2013 | $300.00(>+9900.0%) | $100.00(0.0%) | $200.00(+100.0%) |
| May 2013 | - | $100.00(>+9900.0%) | $100.00(>+9900.0%) |
| Feb 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2012 | - | $0.00 | $0.00 |
| Aug 2012 | $0.00 | - | - |
FAQ
- What is the all time high annual D&A for Relmada Therapeutics?
- What is the all time high quarterly D&A for Relmada Therapeutics?
- What is the all time high TTM D&A for Relmada Therapeutics?
What is the all time high annual D&A for Relmada Therapeutics?
Relmada Therapeutics all-time high annual depreciation & amortization is $85.30 K
What is the all time high quarterly D&A for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly depreciation & amortization is $27.60 K
What is the all time high TTM D&A for Relmada Therapeutics?
Relmada Therapeutics all-time high TTM depreciation & amortization is $92.70 K